Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2000

View Archived Issues

Inspire reports synthesis of more stable P2Y2 agonists

Stem cell transplantation induces remission in persistent SLE

Testing reveals lurtotecan is less active than its low-clearance formulation

Cancer vaccine shows potential for decreasing risk of relapse and death

Low-dose transdermal testosterone tested in chronic stable angina

Bayer's MTP inhibitor assessed preclinically

Dual ETA/ETB antagonist provides hemodynamic benefits in CHF

Selective dopamine agonist provides antiarrhythmic benefits in chronic heart failure

Schering AG's Yasmin receives European-wide approval

Safety and efficacy data reported on AstraZeneca's P2T receptor antagonist in PTCA

Watson completes acquisition of Schein

Ezetimibe inhibits cholesterol absorption; tissue localization explored

Roxifiban inhibits platelet aggregation dose-dependently in CAD patients

AstraZeneca's rosuvastatin causes rapid reductions in LDL cholesterol

LU-135252 normalizes pulmonary arterial pressure and blood pressure in two experimental models

Lilly reports synthesis of novel mGlu2/3 agonists and antagonists

Novartis updates transplantation pipeline at ongoing congress

Tablet form of Rapamune receives FDA approval

Herceptin approved in E.U. for treatment of HER2-positive metastatic breast cancer

Matrix metalloproteinase inhibitors claimed by Aventis

SmithKline Beecham reports compounds useful for treating cytokine-mediated disorders

Neurogen discloses new series of compounds interacting with dopamine D4 receptors

Merck & Co. claims compounds useful for treating cognition disorders

Pharmacia presents new antiviral agents

HIV integrase inhibitors disclosed by Shionogi

Viral protein products reduce transplant rejection in preclinical study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...